| scholarly article | Q13442814 |
| P50 | author | Julie Brocard | Q80062105 |
| P2093 | author name string | Isabelle Marty | |
| David Bendahan | |||
| Sarah Oddoux | |||
| Jacques Brocard | |||
| Benoit Giannesini | |||
| Joël Lunardi | |||
| Peter Szentesi | |||
| Julie Brocard | |||
| Julien Fauré | |||
| Laszlo Csernoch | |||
| Annie Schweitzer | |||
| Karine Pernet-Gallay | |||
| P2860 | cites work | Absence of the beta subunit (cchb1) of the skeletal muscle dihydropyridine receptor alters expression of the alpha 1 subunit and eliminates excitation-contraction coupling | Q24680364 |
| Modulation of L-type Ca2+ current but not activation of Ca2+ release by the gamma1 subunit of the dihydropyridine receptor of skeletal muscle | Q24802046 | ||
| Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane | Q28248323 | ||
| Enhanced resistance to fatigue and altered calcium handling properties of sarcalumenin knockout mice | Q28509838 | ||
| Cloning and characterization of a new isoform of skeletal muscle triadin | Q28575170 | ||
| Triadin (Trisk 95) overexpression blocks excitation-contraction coupling in rat skeletal myotubes | Q28576225 | ||
| Altered expression of triadin 95 causes parallel changes in localized Ca2+ release events and global Ca2+ signals in skeletal muscle cells in culture | Q28578879 | ||
| Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2. | Q28584945 | ||
| Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene | Q28587644 | ||
| Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin-1 | Q28589478 | ||
| Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities | Q28592366 | ||
| Improved method for accurate and efficient quantification of MRS data with use of prior knowledge | Q32172320 | ||
| Functional interaction of the cytoplasmic domain of triadin with the skeletal ryanodine receptor | Q33859373 | ||
| Identification of triadin 1 as the predominant triadin isoform expressed in mammalian myocardium | Q33875009 | ||
| Localization and characterization of the calsequestrin-binding domain of triadin 1. Evidence for a charged beta-strand in mediating the protein-protein interaction | Q33896739 | ||
| The asp-rich region at the carboxyl-terminus of calsequestrin binds to Ca(2+) and interacts with triadin | Q33927847 | ||
| Human skeletal muscle triadin: gene organization and cloning of the major isoform, Trisk 51. | Q34186302 | ||
| Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum | Q34308863 | ||
| Location of ryanodine receptor binding site on skeletal muscle triadin | Q34487763 | ||
| Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle | Q35103866 | ||
| Structural analysis of muscle development: transverse tubules, sarcoplasmic reticulum, and the triad | Q35491643 | ||
| Ca(2+) sparks operated by membrane depolarization require isoform 3 ryanodine receptor channels in skeletal muscle. | Q35691137 | ||
| Altered stored calcium release in skeletal myotubes deficient of triadin and junctin | Q37060519 | ||
| Formation of junctions involved in excitation-contraction coupling in skeletal and cardiac muscle. | Q37463586 | ||
| Triadin: what possible function 20 years later? | Q37464481 | ||
| Measurements of ATP binding on the large cytoplasmic loop of the sarcoplasmic reticulum Ca(2+)-ATPase overexpressed in Escherichia coli. | Q38309115 | ||
| Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins | Q40315222 | ||
| Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. | Q41583686 | ||
| Localization of the N-terminal and C-terminal ends of triadin with respect to the sarcoplasmic reticulum membrane of rabbit skeletal muscle | Q41825445 | ||
| Triadins are not triad-specific proteins: two new skeletal muscle triadins possibly involved in the architecture of sarcoplasmic reticulum | Q41975814 | ||
| Junctin and calsequestrin overexpression in cardiac muscle: the role of junctin and the synthetic and delivery pathways for the two proteins | Q44524077 | ||
| Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease | Q45010236 | ||
| Molecular interaction between ryanodine receptor and glycoprotein triadin involves redox cycling of functionally important hyperreactive sulfhydryls. | Q45951705 | ||
| Localization and partial characterization of the oligomeric disulfide-linked molecular weight 95,000 protein (triadin) which binds the ryanodine and dihydropyridine receptors in skeletal muscle triadic vesicles | Q47427322 | ||
| Primary structure and topological analysis of a skeletal muscle-specific junctional sarcoplasmic reticulum glycoprotein (triadin) | Q48115770 | ||
| Isolation of a terminal cisterna protein which may link the dihydropyridine receptor to the junctional foot protein in skeletal muscle. | Q50877901 | ||
| In vivo functional analysis of the Hoxa-1 3' retinoic acid response element (3'RARE). | Q52197549 | ||
| Retrograde regulation of store-operated calcium channels by the ryanodine receptor-associated protein triadin 95 in rat skeletal myotubes | Q58124984 | ||
| Molecular interactions of the junctional foot protein and dihydropyridine receptor in skeletal muscle triads | Q68458712 | ||
| Exploration of delta-subunit interactions in beef heart mitochondrial F1-ATPase by monoclonal antibodies | Q69057196 | ||
| Specific absence of the alpha 1 subunit of the dihydropyridine receptor in mice with muscular dysgenesis | Q69326252 | ||
| Mechanisms underlying reduced maximum shortening velocity during fatigue of intact, single fibres of mouse muscle | Q74645021 | ||
| Dual regulation of the skeletal muscle ryanodine receptor by triadin and calsequestrin | Q77299816 | ||
| P433 | issue | 50 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 34918-34929 | |
| P577 | publication date | 2009-10-19 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Triadin deletion induces impaired skeletal muscle function | |
| P478 | volume | 284 |
| Q35126961 | A new cytoplasmic interaction between junctin and ryanodine receptor Ca2+ release channels |
| Q64984483 | A unique triadin exon deletion causing a null phenotype. |
| Q24307681 | Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human |
| Q28509794 | Calsequestrin (CASQ1) rescues function and structure of calcium release units in skeletal muscles of CASQ1-null mice |
| Q104111317 | Calsequestrin: a well-known but curious protein in skeletal muscle |
| Q48053644 | Cannabinoid signalling inhibits sarcoplasmic Ca2+ release and regulates excitation-contraction coupling in mammalian skeletal muscle. |
| Q34007314 | Caveolin 3 is associated with the calcium release complex and is modified via in vivo triadin modification |
| Q51136294 | Congenital myopathy associated with the triadin knockout syndrome. |
| Q38970694 | Core skeletal muscle ryanodine receptor calcium release complex. |
| Q35063164 | Cyclization of the intrinsically disordered α1S dihydropyridine receptor II-III loop enhances secondary structure and in vitro function. |
| Q57181503 | Deletion of the microtubule-associated protein 6 (MAP6) results in skeletal muscle dysfunction |
| Q37390949 | Dietary selenium augments sarcoplasmic calcium release and mechanical performance in mice. |
| Q42809439 | Distinct regions of triadin are required for targeting and retention at the junctional domain of the sarcoplasmic reticulum |
| Q87204696 | Effects of fluvastatin and coenzyme Q10 on skeletal muscle in normo- and hypercholesterolaemic rats |
| Q37435413 | Enhancement of neuromuscular dynamics and strength behavior using extremely low magnitude mechanical signals in mice |
| Q42046918 | Excitation-Contraction Coupling Alterations in Myopathies |
| Q34101915 | Excitation-contraction coupling and minor triadic proteins in low-frequency fatigue |
| Q54551370 | Fluvastatin-induced alterations of skeletal muscle function in hypercholesterolaemic rats. |
| Q37589625 | Functional Characterization of a Central Core Disease RyR1 Mutation (p.Y4864H) Associated with Quantitative Defect in RyR1 Protein. |
| Q90678000 | Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse |
| Q49919753 | Knockout of human muscle genes revealed by large scale whole-exome studies |
| Q35193342 | On the footsteps of Triadin and its role in skeletal muscle |
| Q37945102 | Reciprocal dihydropyridine and ryanodine receptor interactions in skeletal muscle activation |
| Q34642130 | Reduced gain of excitation-contraction coupling in triadin-null myotubes is mediated by the disruption of FKBP12/RyR1 interaction |
| Q28078420 | Review of RyR1 pathway and associated pathomechanisms |
| Q52639740 | RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling. |
| Q37705608 | Ryanodine receptor studies using genetically engineered mice |
| Q35642611 | The couplonopathies: A comparative approach to a class of diseases of skeletal and cardiac muscle. |
| Q50587074 | Three residues in the luminal domain of triadin impact on Trisk 95 activation of skeletal muscle ryanodine receptors. |
| Q98772000 | Transcriptome Profiling across Five Tissues of Giant Panda |
| Q26801317 | Triadin regulation of the ryanodine receptor complex |
| Q34329037 | Triadin/Junctin double null mouse reveals a differential role for Triadin and Junctin in anchoring CASQ to the jSR and regulating Ca(2+) homeostasis |
| Q97652817 | Trisk 95 as a novel skin mirror for normal and diabetic systemic glucose level |
Search more.